Meet Our World‑Class Facilities
JYMed Peptide operates two state‑of‑the‑art manufacturing sites in China, each designed to meet global cGMP standards while delivering integrated peptide API and sterile formulation capabilities.
Hubei API manufacturing site
Peptide API Manufacturing Excellence
Situated in the Xian’an Economic Development Zone, our Hubei facility is the cornerstone of JYMed Peptide’s large‑scale peptide API production. Spanning a 300‑acre campus with more than 54,000 m² of cutting‑edge infrastructure, this site was built from the ground up to support complex peptide synthesis and high‑volume production for both commercial and clinical markets. The facility integrates Solid Phase Peptide Synthesis (SPPS) and Liquid Phase Peptide Synthesis (LPPS) technologies, supported by automated preparative chromatography systems, continuous purification processes, and extensive capacity for future expansion. With strict adherence to international cGMP standards, the Hubei site has successfully passed multiple US FDA and NMPA audits, earning its reputation as a reliable partner for pharmaceutical and biotech companies worldwide.
Hubei JXBio
Diving into the Numbers
54,000 m²: size of the Hubei API campus, housing 30 000 L + of SPPS/LPPS reactor volume.
10 cGMP lines: supporting large (5–50 kg), small/medium (100 g–5 kg) and cosmetic (1–100 kg) batch scales.
SPPS/LPPS reactor capacity
4+ tons: current annual peptide output, expanding to 10+ tons by 2027.
Smart Design, Scalable Solutions
Infrastructure Highlights:
Four dedicated peptide production workshops
Purpose-built GMP suites designed for scalable synthesis, ensuring efficient batch production with minimized cross-contamination risk.
Advanced quality control and R&D buildings
Equipped with cutting-edge analytical technologies and formulation labs to support continuous innovation and compliance.
Class A & B warehouses and full logistics support
Validated storage environments with temperature and humidity control, enabling secure handling of raw materials and finished products.
On‑site solvent recovery, power, waste management, and water treatment
Integrated utilities infrastructure that supports sustainability, regulatory compliance, and uninterrupted operations.
Shenzhen FDF manufacturing site
Sterile Formulation & CDMO Services
Located in Shenzhen’s thriving biotech hub, Shenzhen JXBio is our center of excellence for peptide formulation and fill‑finish services. Established in 2013 as a wholly owned subsidiary of JYMed Peptide, the facility houses multiple GMP‑compliant production lines for cartridges, small‑volume injections, and lyophilized powders. It provides an integrated platform for contract development and manufacturing (CDMO) services, supporting clients from clinical development through to commercial supply. Our highly trained technical teams implement rigorous process controls, sterile handling protocols, and state‑of‑the‑art filling and freeze‑drying equipment to ensure every batch meets the highest international standards. Having successfully passed repeated NMPA cGMP audits and multiple PAI inspections, Shenzhen JXBio has become a trusted partner for pharmaceutical companies looking to bring innovative peptide therapies to market.
Smart Design, Scalable Solutions
Infrastructure Highlights:
Passed multiple NMPA cGMP audits and two PAI audits
Our facilities have successfully undergone multiple inspections by China’s National Medical Products Administration (NMPA), including two Pre-Approval Inspections (PAIs), demonstrating robust compliance with national regulatory standards for pharmaceutical manufacturing.
Supports IND, ANDA, and NDA regulatory filings worldwide
We provide comprehensive regulatory support for global submissions, including Investigational New Drug (IND), Abbreviated New Drug Application (ANDA), and New Drug Application (NDA) filings, ensuring alignment with FDA, NMPA, and EMA requirements.
Shenzhen JXBio
Diving into the Numbers
Four GMP‑compliant formulation lines for cartridge, small‑volume, and lyophilized powder injections
Syringe line filling speed: 200 vials/minute (30M vials/year)
Cartridge line filling speed: 70 bottles/minute (10M bottles/year)
Freeze‑dryer line capacity: 22,000 vials per batch (5M vials/year)